Passage Bio Taps Advisor as Analysts See 125% Upside for PASG
Analysts project a 125% surge in Passage Bio shares over 12 months despite a 50% year-to-date decline. Passage Bio Inc (NASDAQ:PASG) has engaged Wedbush PacGrow as a financial advisor to explore strategic alternatives aimed at maximizing shareholder value. The move follows